Psyched Wellness Unveils New Product Name and Visual Identity Elements
Toronto, Ontario--(Newsfile Corp. - March 30, 2022) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, has unveiled its official branding and visuals for its Amanita Muscaria Extract (AME-1) today as the company prepares for a Spring launch in the USA to meet consumer demand for ethically sourced, high-quality Amanita Muscaria products....
2022-03-30 7:30 AM EDT
Psyched Wellness and the National Research Council of Canada Announce Preliminary Data from Studies of Neuroprotective Properties of AME-1
Toronto, Ontario--(Newsfile Corp. - March 24, 2022) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce the preliminary data from the National Research Council of Canada (NRC), from studies on the neuroprotective properties of AME-1, Psyched's proprietary extract from the Amanita Muscaria mushroom.The study was the...
2022-03-24 11:00 AM EDT
Psyched Wellness GRAS Dossier Approved by Panel of Experts, Providing Green Light to Market Products in the United States
Toronto, Ontario--(Newsfile Corp. - March 8, 2022) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE:5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that an independent review panel of scientific experts has concluded that Psyched's key proprietary extract of Amanita Muscaria, AME-1, is Generally Recognized As Safe (GRAS) as a bulk ingredient. The successful...
2022-03-08 7:30 AM EST
Psyched Wellness Announces Key Findings from the 90-Day Oral Toxicity Study on AME-1
Toronto, Ontario--(Newsfile Corp. - February 15, 2022) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce the key results from the 90-day oral toxicity preclinical study on its proprietary extract of the Amanita Muscaria mushroom (AME-1), with its contract research organization (CRO) partner. The study was the...
2022-02-15 7:30 AM EST
Psyched Wellness Announces Additional Positive Results from the 14-day Oral Toxicity Study of AME-1
Toronto, Ontario--(Newsfile Corp. - February 3, 2022) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to report additional positive findings from the preclinical 14-day oral toxicity study with Amanita Muscaria (AME-1), which was performed in conjunction with an analysis of its impact on gut epithelial cells. The invivo...
2022-02-03 7:30 AM EST
Psyched Wellness Announces Launch of New Logo, Branding, and Website, Prepares to Release Industry-First Amanita Muscaria Tincture
Toronto, Ontario--(Newsfile Corp. - February 1, 2022) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that the Company has successfully launched its new logo, branding, and website. This is a major milestone for the only publicly traded company focusing on the Amanita Muscaria (AM) mushroom, as the Company...
2022-02-01 7:52 AM EST
Psyched Wellness Implements RSU Plan and Grant RSUS
Toronto, Ontario--(Newsfile Corp. - January 28, 2022) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, announced today that it has implemented a restricted share unit award plan (the "RSU Plan"). The following is a summary of the material provisions of the RSU Plan. It is not a comprehensive discussion of all of the terms and...
2022-01-28 4:30 PM EST
Psyched Wellness Provides Update on Anti-Inflammatory Study with the National Research Council of Canada
Toronto, Ontario--(Newsfile Corp. - January 26, 2022) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company focused on the production and distribution of artisanal functional mushrooms, is pleased to announce that the preliminary data from its study with the National Research Council of Canada (NRC) indicates that AME-1, the Company's key proprietary extract, holds anti-inflammatory properties. The study is examining the...
2022-01-26 9:48 AM EST
Psyched Wellness Announces Vantage Hemp Co. as Contract Manufacturing Organization Partner to Bring AME-1-derived Products to Market
Toronto, Ontario--(Newsfile Corp. - January 18, 2022) - Psyched Wellness Ltd., (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce Vantage Hemp Co. as the Company's contract manufacturing organization ("CMO") partner, facilitating the path to market for Psyched's AME-1-derived consumer products.The agreement includes extraction, commercial...
2022-01-18 7:30 AM EST
Psyched Wellness Announces Path to Market for AME-1-derived Products in the USA
Toronto, Ontario--(Newsfile Corp. - December 16, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that it is moving forward with its regulatory strategy to launch its Amanita Muscaria extract ("AME-1")-derived consumer products in-stores in the United States market in the second quarter of 2022.To achieve...
2021-12-16 7:30 AM EST
Psyched Wellness Hires Del Mahabadi as Digital Marketing Consultant to Drive AME-1 Product Launch
Toronto, Ontario--(Newsfile Corp. - December 14, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that it has hired Del Mahabadi as Digital Marketing Consultant to drive the launch of the Company's AME-1 products to market next year. Ms. Mahabadi is a highly successful marketer and leader with a long track...
2021-12-14 8:35 AM EST
Psyched Wellness Announces Completion of Its 90 Day Oral Toxicity Study
Toronto, Ontario--(Newsfile Corp. - December 6, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that further to the please release dated June 28, 2021, the 90-day oral toxicity study has been completed. KGK, the Company's CRO partner, is now completing the 28-day recovery period, after which a tissue...
2021-12-06 7:30 AM EST
Psyched Wellness Presents AME-1 to Health Canada in Pre-Submission Meeting
Toronto, Ontario--(Newsfile Corp. - December 1, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that on November 30, 2021, representatives from the Company and KGK Science, the Company's contract research organization (CRO), presented AME-1, Psyched's proprietary extract of the Amanita Muscaria mushroom,...
2021-12-01 7:30 AM EST
Psyched Wellness to Present at H.C. Wainwright 2nd Annual Psychedelics Conference, 2021
Toronto, Ontario--(Newsfile Corp. - November 30, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, today announced that Chief Executive Officer, Jeffrey Stevens, and David Shisel, Chief Operating Officer, will present at H.C. Wainwright's 2nd Annual Psychedelics Conference on Monday, December 6th, 2021.A recording of Psyched's...
2021-11-30 11:50 AM EST
Psyched Wellness Appoints Chief Commercial Officer to Lead Sales and Marketing of AME-1 and Launch CPG Products
Toronto, Ontario--(Newsfile Corp. - November 23, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that it has appointed Matthew Singh as Chief Commercial Officer. Mr. Singh will drive the Company's development into a full-scale packaged goods provider as it prepares to launch its Amanita Muscaria...
2021-11-23 7:00 AM EST
Psyched Wellness to Present at Grizzle Psychedelics Con on Monday, November 22, 2021
Toronto, Ontario--(Newsfile Corp. - November 17, 2021) - Psyched Wellness Ltd. (CSE:PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, today announced that Chief Executive Officer, Jeffrey Stevens will participate as a featured speaker in the Grizzle Psychedelics Con 1x1 to be held on Monday, November 22, 2021.Mr. Stevens will present at 12:40pm ET. The presentation...
2021-11-17 10:52 AM EST
Psyched Wellness Announces That the Amanita Muscaria Mushroom Has Been Successfully Added to the Natural Health Products Ingredients Database (NHPID) of Canada
Toronto, Ontario--(Newsfile Corp. - November 3, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that Health Canada has approved the Company's submission to have the Amanita Muscaria mushroom added to The Natural Health Products Ingredients Database (NHPID) of Canada.Following Psyched's extensive...
2021-11-03 7:30 AM EDT
Psyched Wellness Announces Participation in Microdose's Wonderland: Miami on November 8-9, 2021
Toronto, Ontario--(Newsfile Corp. - November 1, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, today announced that Chief Executive Officer, Jeffrey Stevens, will participate in Microdose's Wonderland: Miami Conference on November 8-9, 2021. Wonderland: Miami will be held at the Adrienne Arsht Center for the Performing Arts in...
2021-11-01 10:28 AM EDT
Psyched Wellness Announces Preliminary Data Showing Potential New Functional Property and Health Benefit of Amanita Muscaria Mushroom (AME-1) To Inhibit Human Mast Cell Activation
Toronto, Ontario--(Newsfile Corp. - October 19, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce the preliminary data revealing a potential new functional property and health benefit of AME-1.Preliminary data that has been generated in tests done by the National Research Council of Canada (NRC) shows that...
2021-10-19 7:30 AM EDT
Psyched Wellness Announces Commencement of Next Pre-Clinical Study on AME-1
Toronto, Ontario--(Newsfile Corp. - October 7, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that KGK Science, a licensed contract research organization (CRO) in Canada, is commencing the next pre-clinical trial study on Psyched's key proprietary extract, Amanita Muscaria (AME-1).The trial will comprise...
2021-10-07 7:00 AM EDT